OnKure, Inc announced the appointment of Rogan Nunn as General Counsel and Secretary. Mr Nunn will be a member of OnKure’s Executive Team, reporting to Nicholas Saccomano, President and Chief Executive Officer, and will oversee all aspects of the Company’s legal and compliance functions.
Who to call at OnKure Therapeutics, and when
A new leader at OnKure Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day OnKure Therapeutics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at OnKure Therapeutics, from your own LinkedIn network
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
OnKure Therapeutics
Location
6707 WINCHESTER CIRCLE
Boulder, Colorado, United States
About
OnKure Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of best-in-class precision medicines that target biologically significant and well-validated pharmacological pathways, with a focus on oncogenic mutations in phosphoinositide 3-kinase alpha (PI3Kα).
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment OnKure Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
BoulderBiotechnologyHealthcareTherapeuticsPharmaceuticalBiopharma